These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 35220969)

  • 41. [Whole exome sequencing and whole genome sequencing in undiagnosed disease: of value for certain patient populations].
    Linthorst GE; Hollak CEM
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Translational Diagnostics: An In-House Pipeline to Validate Genetic Variants in Children with Undiagnosed and Rare Diseases.
    Pijuan J; Rodríguez-Sanz M; Natera-de Benito D; Ortez C; Altimir A; Osuna-López M; Roura M; Ugalde M; Van de Vondel L; Reina-Castillón J; Fons C; Benítez R; Nascimento A; Hoenicka J; Palau F
    J Mol Diagn; 2021 Jan; 23(1):71-90. PubMed ID: 33223419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases.
    Pena LDM; Jiang YH; Schoch K; Spillmann RC; Walley N; Stong N; Rapisardo Horn S; Sullivan JA; McConkie-Rosell A; Kansagra S; Smith EC; El-Dairi M; Bellet J; Keels MA; Jasien J; Kranz PG; Noel R; Nagaraj SK; Lark RK; Wechsler DSG; Del Gaudio D; Leung ML; Hendon LG; Parker CC; Jones KL; ; Goldstein DB; Shashi V
    Genet Med; 2018 Apr; 20(4):464-469. PubMed ID: 28914269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implementation of Exome Sequencing to Identify Rare Genetic Diseases.
    Udupa P; Ghosh DK
    Methods Mol Biol; 2024; 2719():79-98. PubMed ID: 37803113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Six years' accomplishment of the Initiative on Rare and Undiagnosed Diseases: nationwide project in Japan to discover causes, mechanisms, and cures.
    Takahashi Y; Date H; Oi H; Adachi T; Imanishi N; Kimura E; Takizawa H; Kosugi S; Matsumoto N; Kosaki K; Matsubara Y; ; Mizusawa H
    J Hum Genet; 2022 Sep; 67(9):505-513. PubMed ID: 35318459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study.
    Shickh S; Gutierrez Salazar M; Zakoor KR; Lázaro C; Gu J; Goltz J; Kleinman D; Noor A; Khalouei S; Mighton C; Reble E; Kodida R; Bombard Y; DiTroia S; Baxter S; Watkins N; Care M; Adler A; Horsburgh S; Morar O; Murphy J; Nevay DL; Szybowska M; Aronson M; Panchal S; Godoy R; Holter S; Randall Armel S; Semotiuk K; Elser C; Kim RH; Chitayat D; So J; Faghfoury H; Silver J; Morel CF; Lerner-Ellis J
    J Med Genet; 2021 Apr; 58(4):275-283. PubMed ID: 32581083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identifying digenic disease genes via machine learning in the Undiagnosed Diseases Network.
    Mukherjee S; Cogan JD; Newman JH; Phillips JA; Hamid R; ; Meiler J; Capra JA
    Am J Hum Genet; 2021 Oct; 108(10):1946-1963. PubMed ID: 34529933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Massively parallel identification of functionally consequential noncoding genetic variants in undiagnosed rare disease patients.
    McQuerry JA; Mclaird M; Hartin SN; Means JC; Johnston J; Pastinen T; Younger ST
    Sci Rep; 2022 May; 12(1):7576. PubMed ID: 35534523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A scoping review and proposed workflow for multi-omic rare disease research.
    Kerr K; McAneney H; Smyth LJ; Bailie C; McKee S; McKnight AJ
    Orphanet J Rare Dis; 2020 Apr; 15(1):107. PubMed ID: 32345347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Whole-genome sequencing as a first-tier diagnostic framework for rare genetic diseases.
    Nisar H; Wajid B; Shahid S; Anwar F; Wajid I; Khatoon A; Sattar MU; Sadaf S
    Exp Biol Med (Maywood); 2021 Dec; 246(24):2610-2617. PubMed ID: 34521224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical utility of whole-exome sequencing in rare diseases: Galactosialidosis.
    Prada CE; Gonzaga-Jauregui C; Tannenbaum R; Penney S; Lupski JR; Hopkin RJ; Sutton VR
    Eur J Med Genet; 2014 Jul; 57(7):339-344. PubMed ID: 24769197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The RD-Connect Genome-Phenome Analysis Platform: Accelerating diagnosis, research, and gene discovery for rare diseases.
    Laurie S; Piscia D; Matalonga L; Corvó A; Fernández-Callejo M; Garcia-Linares C; Hernandez-Ferrer C; Luengo C; Martínez I; Papakonstantinou A; Picó-Amador D; Protasio J; Thompson R; Tonda R; Bayés M; Bullich G; Camps-Puchadas J; Paramonov I; Trotta JR; Alonso A; Attimonelli M; Béroud C; Bros-Facer V; Buske OJ; Cañada-Pallarés A; Fernández JM; Hansson MG; Horvath R; Jacobsen JOB; Kaliyaperumal R; Lair-Préterre S; Licata L; Lopes P; López-Martín E; Mascalzoni D; Monaco L; Pérez-Jurado LA; Posada de la Paz M; Rambla J; Rath A; Riess O; Robinson PN; Salgado D; Smedley D; Spalding D; 't Hoen PAC; Töpf A; Zaharieva I; Graessner H; Gut IG; Lochmüller H; Beltran S
    Hum Mutat; 2022 Jun; 43(6):717-733. PubMed ID: 35178824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosing rare diseases after the exome.
    Frésard L; Montgomery SB
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Model Organisms Facilitate Rare Disease Diagnosis and Therapeutic Research.
    Wangler MF; Yamamoto S; Chao HT; Posey JE; Westerfield M; Postlethwait J; ; Hieter P; Boycott KM; Campeau PM; Bellen HJ
    Genetics; 2017 Sep; 207(1):9-27. PubMed ID: 28874452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Copy-number variants in clinical genome sequencing: deployment and interpretation for rare and undiagnosed disease.
    Gross AM; Ajay SS; Rajan V; Brown C; Bluske K; Burns NJ; Chawla A; Coffey AJ; Malhotra A; Scocchia A; Thorpe E; Dzidic N; Hovanes K; Sahoo T; Dolzhenko E; Lajoie B; Khouzam A; Chowdhury S; Belmont J; Roller E; Ivakhno S; Tanner S; McEachern J; Hambuch T; Eberle M; Hagelstrom RT; Bentley DR; Perry DL; Taft RJ
    Genet Med; 2019 May; 21(5):1121-1130. PubMed ID: 30293986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical exome sequencing for genetic identification of rare Mendelian disorders.
    Lee H; Deignan JL; Dorrani N; Strom SP; Kantarci S; Quintero-Rivera F; Das K; Toy T; Harry B; Yourshaw M; Fox M; Fogel BL; Martinez-Agosto JA; Wong DA; Chang VY; Shieh PB; Palmer CG; Dipple KM; Grody WW; Vilain E; Nelson SF
    JAMA; 2014 Nov; 312(18):1880-7. PubMed ID: 25326637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exome sequencing a review of new strategies for rare genomic disease research.
    Brown TL; Meloche TM
    Genomics; 2016 Oct; 108(3-4):109-114. PubMed ID: 27387609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correspondence on "Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions" by Lavelle et al.
    Grosse SD; Gudgeon JM
    Genet Med; 2022 Dec; 24(12):2595-2596. PubMed ID: 36129466
    [No Abstract]   [Full Text] [Related]  

  • 60. Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities.
    Tetreault M; Bareke E; Nadaf J; Alirezaie N; Majewski J
    Expert Rev Mol Diagn; 2015 Jun; 15(6):749-60. PubMed ID: 25959410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.